6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
20m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
53m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
53m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
53m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
53m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Lipocine Inc (NASDAQ:LPCN) — investor relations, events, news, and company updates on 6ix.

Latest News

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

Lipocine Announces Financial Results for the Full Year Ended December 31, 2025

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Financials

Revenue

$1.98 M

Market Cap

$14.16 M

EPS

-1.77

Community Chat

Ask AI